Lynx, a fintech platform for healthcare payments, has raised $27 million in Series A funding to scale its operations, the company recently announced. Boston-based Lynx works with health plans ...

Novartis is expanding its prospects in cardiometabolic disease by striking a deal to acquire Anthos Therapeutics, a company in pivotal testing with a blood clot-preventing drug that could offer ...

This year, venture capitalists in the digital health landscape have many more quality investment opportunities than they did ...

The obesity drugs currently available address a broad swath of patients who struggle to manage their weight. While Aardvark Therapeutics is interested in serving this market, first it wants to ...

Bain Capital, an investment firm that has spread its life sciences bets mainly across companies developing novel new medicines, is acquiring Mitsubishi Tanabe Pharma Corporation in a multi-billion ...

Welcome back to another episode of MedCity FemFwd, a podcast dedicated to discussing the breakthroughs and challenges in women’s health. In this episode, we’re joined by Emily Lindemer, an ...

The serial entrepreneur and CEO of Transcarent has dismissed care navigation companies in the past. What led him to buy ...

House Republicans introduced a proposal seeking to cut Medicaid spending by hundreds of billions of dollars. Healthcare ...

CMS recently issued a statement saying that it's continuing the Medicare Drug Price Negotiation Program but is leaving the ...

The Senate confirmed Robert F. Kennedy Jr. as secretary of the Department of Health and Human Services. Healthcare leaders ...

In the past couple years, AI-powered ambient documentation tools have done a commendable job at reducing clinicians’ administrative burden — and the initial success of these tools points to a ...

Drugs that activate the GLP-1 receptor transformed the treatment of obesity, but biotech company Metsera contends that limitations keep them from expanding their reach. The weekly injections and ...